comparemela.com
Home
Live Updates
PharmAbcines U.S. Subsidiary, Wincal Biopharm, to Present Preclinical Data from its Proprietary OPC Platform Targeting Ocular Diseases at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2024 : comparemela.com
PharmAbcine's U.S. Subsidiary, Wincal Biopharm, to Present Preclinical Data from its Proprietary OPC Platform Targeting Ocular Diseases at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2024
DAEJEON, South Korea, April 23, 2024 /PRNewswire/ -- PharmAbcine, Inc. ("PharmAbcine" or the "Company") (KOSDAQ: 208340), a clinical-stage public company
Related Keywords
South San Francisco ,
California ,
United States ,
South Korea ,
Daejeon ,
Taejon Gwangyoksi ,
Thailand ,
Venice Chiueh ,
Wincal Biopharm Wincalbio ,
Taeweon Lee ,
Seattle Convention Center ,
Pharmabcine Inc ,
Association For Research ,
Wincal Biopharm Inc ,
Wincal Biopharm ,
Ocular Penetration Carrier ,
Chief Scientific Officer ,
Start Time ,
March Building ,
Penetration Carrier ,
Thailand Business ,
comparemela.com © 2020. All Rights Reserved.